Methylstenbolone
Orally taken muscle-building steroid: its effect is not proven in humans, but it can cause severe liver damage; banned in sport.

DETAILED OVERVIEW
What is Methylstenbolone?
Methylstenbolone (M-Sten, Ultradrol, Methyl-D) is a man-made muscle-building steroid that can be taken by mouth. In the United States it was sold as a dietary supplement; several manufacturers received warning letters from the American drug regulator, and since 2014 it has been a controlled substance. In the European Union it is illegal without a prescription. Its effect is not proven in humans, but its risks are well documented.
The risk of liver damage is very high: in healthy young men, cholestatic hepatitis (liver inflammation with blocked bile flow) and liver failure developed within weeks, in some cases ending in a liver transplant. It worsens cholesterol values (the good HDL falls), raises blood pressure and shuts down the body's own testosterone production. The strong androgen effect can cause acne, aggression, hair loss and an enlarged prostate; in women it causes irreversible masculinization, and in pregnancy it can harm the fetus. WADA bans it, and using it leads to disqualification.
Mechanism
AR agonist (anabolic 660 / androgenic 660)
Half-life
8-12 hours
Legal status
USA: controlled since 2014; no uniform regulation in the EU
No anecdote collected yet.
Data console
Lab data
Rahnema CD, Crosnoe LE, Kim ED . Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem. Andrology. 2015;3(2):150-5..
Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schänzer W. . Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom. 2008;43(7):892-902..
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Severe hepatotoxicity: as a 17-alpha-methylated oral steroid it caused documented acute cholestatic hepatitis and fulminant liver failure at 5-15 mg/day within 3-6 weeks (Robles-Diaz 2015), some cases progressing to liver transplant. Jaundice, pruritus, dark urine, elevated ALT/AST/bilirubin.
- Drastic lipid deterioration: oral 17-aa steroids typically crash HDL cholesterol and raise LDL, producing an unfavourable cardiovascular risk profile even within a short cycle.
- Marked androgenic effects: the symmetric 660:660 ratio means androgenic/prostatic activity is as strong as the anabolic effect, so acne, oily skin, androgenic hair loss (in predisposed users) and prostate hypertrophy occur.
- HPTA suppression: shutdown of endogenous testosterone production, testicular shrinkage, reduced libido and sperm count after the cycle, which without PCT (Clomid/Nolvadex) can cause prolonged hypogonadism.
- Raised blood pressure and cardiovascular strain: the steroid and lipid effects can cause hypertension and increased cardiovascular stress even during the short cycle.
- Mood and behavioural changes: increased aggression/irritability and sleep disturbance linked to the strong androgenic activity.
- Virilization in women: irreversible masculinising effects (voice deepening, hirsutism, clitoral enlargement) due to the strong androgenicity, unsuitable for women.
Contraindications · 7
- Any pre-existing liver disorder, elevated liver enzymes or prior drug-induced liver injury, an absolute contraindication given the documented fulminant hepatotoxicity.
- Pregnancy and breastfeeding: the strong androgenic effect severely harms the fetus (virilization), so it is strictly contraindicated in pregnancy.
- Women and adolescents: not to be used due to the marked, partly irreversible androgenic/virilizing effects and the risk of premature epiphyseal closure.
- Cardiovascular disease, hypertension or adverse lipid profile: the HDL crash and blood pressure rise worsen pre-existing cardiovascular risk.
- Prostate disease or prostate/breast carcinoma: the strong androgenic activity can stimulate androgen-sensitive tissues.
- Concurrent alcohol use, hepatotoxic drugs or NSAIDs: cumulative liver burden and increased toxicity risk.
- Competitive athletes: it is on the WADA prohibited list and its use leads to disqualification.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem
Rahnema CD, Crosnoe LE, Kim ED
Nutritional supplements cross-contaminated and faked with doping substances
Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schänzer W.
Telegram
Have a question about Methylstenbolone?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.